查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611033

神經血栓清除裝置市場規模、佔有率、趨勢分析報告：按產品、最終用途、地區和細分市場預測，2025-2030 年

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecast, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 154 Pages | 商品交期: 2-10個工作天內

價格

神經血栓切除術設備市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計2030年全球神經血栓切除設備市場規模將達11億美元，2025年至2030年複合年成長率為6.94%。市場成長受到多種因素的推動，例如中風盛行率的增加、不健康生活方式的增加、微創手術需求的增加以及市場參與企業採取的各種策略性舉措。與傳統的開顱手術相比，這些設備簡化了傷口縫合，並在創傷治療更快方面具有記錄的優勢。這些包括容易進入顱內空間、微創性以及由於與神經血栓切除裝置相關的先進設計和功能而簡化困難的手術。

此外，所有年齡層的人對更美觀、更自然的外觀越來越感興趣，以及微創手術期間更少的失血也是市場成長的關鍵促進因素。此類手術預計將比侵入性手術更有助於減少創傷並促進更快的康復。如上所述，隨著神經血栓切除裝置導致失血更少和恢復更快，對微創手術的需求預計將會增加。此外，採用技術先進的產品和快速的產品核可流程預計將在預測期內推動市場成長。各種其他技術已被用於開發用於治療 AIS 和相關病症的神經血栓切除裝置。例如，2023年6月，Penumbra推出了閃電Bolt7動脈血栓切除系統。該設備有助於區分血塊和血流。

神經血栓切除術設備市場報告亮點

  • 從產品來看，由於急性缺血性腦中風盛行率上升以及主要市場參與企業增加產品推出，血栓移除設備將在 2024 年佔據市場主導地位，佔有率為 57.8%。
  • 按最終用途分類，由於醫院醫療設施的改善和先進設備的配備，醫院細分市場在2024年佔據市場主導地位，佔有率為70.4%。
  • 由於急性缺血性腦中風患者的增加，歐洲在 2024 年以 32.9% 的最大銷售佔有率引領市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章神經血栓切除設備市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 神經血栓切除術設備市場分析工具
    • 波特的分析
    • PESTEL分析

第4章神經血栓清除裝置市場：依產品估算與趨勢分析

  • 細分儀表板
  • 神經血栓切除術設備市場：2024 年和 2030 年產品變化分析
  • 凝結獵犬
  • 吸引裝置
  • 勒除器

第5章神經血栓清除裝置市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 神經血栓切除術設備市場：2024 年和 2030 年最終用途變化分析
  • 醫院
  • 急診室
  • 門診手術中心

第6章神經血栓清除裝置市場：區域、估計和趨勢分析

  • 2024 年和 2030 年按地區分類的神經血栓清除設備市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Medtronic
    • Stryker
    • Acandis GmbH
    • Phenox GmbH
    • Penumbra
    • Vesalio, LLC.
    • Terumo Corporation
    • MIVI Neuroscience, Inc.
    • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • Rapid Medical
    • Infinity Neuro
Product Code: GVR-2-68038-941-8

Neurothrombectomy Devices Market Growth & Trends:

The global neurothrombectomy devices market size is expected to reach USD 1.1 billion by 2030, registering a CAGR of 6.94% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

Neurothrombectomy Devices Market Report Highlights:

  • Based on products, clot retrievers segment dominated the market in 2024, with a share of 57.8% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players.
  • Based on end-use, hospital segment dominated the market in 2024 with a share of 70.4% due to improving health care facilities and the availability of advanced equipment in the hospitals.
  • Europe led the market with the maximum revenue share of 32.9% in 2024, owing to the increasing number of patients suffering from acute ischemic stroke in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurothrombectomy Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Neurothrombectomy Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of suppliers
      • 3.4.1.2. Bargaining power of buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological Landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurothrombectomy Devices Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Clot Retrievers
    • 4.3.1. Clot Retrievers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Aspiration/Suction Devices
    • 4.4.1. Aspiration/Suction Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Vascular Snares
    • 4.5.1. Vascular Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurothrombectomy Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurothrombectomy Devices Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Emergency Clinics
    • 5.4.1. Emergency Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Ambulatory Surgical Centers
    • 5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Neurothrombectomy Devices Market Share, By Region, 2024 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. U.S. Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Canada Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.2.4.3. Competitive Scenario
      • 6.2.4.4. Mexico Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. UK Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Germany Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. France Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Italy Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Spain Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Denmark Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Sweden Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Norway Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Japan Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. China Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. India Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Australia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Thailand Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. South Korea Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Brazil Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Argentina Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. South Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Saudi Arabia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. UAE Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Kuwait Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Medtronic
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Stryker
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Acandis GmbH
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Phenox GmbH
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Penumbra
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Vesalio, LLC.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Terumo Corporation
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. MIVI Neuroscience, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Rapid Medical
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. Infinity Neuro
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S neurothrombectomy devices, by end use, 2018 - 2030 (USD Million)
  • Table 8 Canada neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Mexico neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Mexico neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 15 UK neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 UK neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Germany neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 18 Germany neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 19 France neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 France neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Italy neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Italy neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Spain neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Spain neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Denmark neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Sweden neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Sweden neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Norway neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Norway neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 34 China neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 35 China neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Japan neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 38 India neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 39 India neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Australia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 42 South Korea neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 43 South Korea neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Thailand neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 Thailand neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Latin America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Brazil neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Argentina neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 52 Argentina neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Africa neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 60 UAE neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 61 UAE neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 63 Kuwait neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neurothrombectomy device market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Consumer behavior analysis
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Neurothrombectomy device market: Product movement analysis
  • Fig. 19 Segment dashboard
  • Fig. 20 Neurothrombectomy device market product outlook: Key takeaways
  • Fig. 21 Clot retrievers market, 2018 - 2030 (USD Million)
  • Fig. 22 Aspiration/ suction devices market, 2018 - 2030 (USD Million)
  • Fig. 23 Vascular snares market, 2018 - 2030 (USD Million)
  • Fig. 24 Neurothrombectomy device market: End Use movement analysis
  • Fig. 25 Segment dashboard
  • Fig. 26 Neurothrombectomy device market end use outlook: Key takeaways
  • Fig. 27 Hospital market, 2018 - 2030 (USD Million)
  • Fig. 28 Emergency clinics market, 2018 -- 2030 (USD Million)
  • Fig. 29 Ambulatory Surgical Centers market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional outlook, 2024 & 2030
  • Fig. 31 Regional market dashboard
  • Fig. 32 Regional market place: Key takeaways
  • Fig. 33 North America neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 34 US neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 37 UK neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 39 France neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Japan neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 44 China neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 45 India neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Australia neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 51 MEA neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 54 UAE neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 55 Company market share analysis, 2024